Substituted Cyclopentane And Cyclopentene Compounds Useful As Neuraminidase Inhibitors

Details for Australian Patent Application No. 2003212040 (hide)

Owner Biocryst Pharmaceuticals, Inc.

Inventors Montgomery, John A.; Chand, Pooran; Babu, Yarlagadda S.

Agent Hodgkinson McInnes

Pub. Number AU-B-2003212040

Parent 22001

Filing date 10 July 2003

Wipo publication date 14 August 2003

Acceptance publication date 18 August 2005

International Classifications

C07C 069/74 Esters of carboxylic acids

C07D 341/00 Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms

C07D 233/54 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 261/20 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07C 049/597 Ketones

C07C 049/395 Ketones

C07C 049/297 Ketones

C07C 049/105 Ketones

C07C 061/20 Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings

C07C 061/06 Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings

Event Publications

24 July 2003 Complete Application Filed

14 August 2003 Application Open to Public Inspection

  Published as AU-B-2003212040

18 August 2005 Application Accepted

  Published as AU-B-2003212040

15 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003212041-Medical Suture Holding Member

2003212039-Heat Resistant Covering Material